Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors

Clinical trial NCT07280832 · RECRUITING

Trial details

NCT number: NCT07280832
Sponsor: Shanghai JMT-Bio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Locally Advanced or Metastatic Melanoma Unresectable Locally Advanced or Metastatic Urinary Tract Tumors

Start date: 2025-12-17
Primary completion: 2026-11-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.